Back
ALX Oncology Holdings Vs. Neurocrine Biosciences Industry Stock Comparison
Buy
54
ALXO
ALX Oncology Holdings
Last Price:
1.41
Seasonality Move:
3.52%
Buy
57
NBIX
Neurocrine Biosciences
Last Price:
125.67
Seasonality Move:
17.1%
Buy
54
ALX Oncology Holdings (ALXO)
is a Buy
Is ALX Oncology Holdings a Buy, Sell or Hold?
- The current ALX Oncology Holdings [ALXO] share price is $1.41. The Score for ALXO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ALXO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $125.65. The Score for NBIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALXO Stock Price Chart
What is ALX Oncology Holdings's stock price today?
-
The ALX Oncology Holdings share price today is $1.41
The current trend is relatively stagnant and ALXO is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $125.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing slight selling pressure.
ALXO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 47.34 | Sell |
| Chaikin Money Flow: | 625655 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.3 - 1.52) | Sell |
| Bollinger Bands (100): | (0.93 - 4.73) | Sell |
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.09 | Buy |
| Relative Strength Index (14 RSI): | 58.45 | Buy |
| Chaikin Money Flow: | -36833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (117.05 - 125.11) | Buy |
| Bollinger Bands (100): | (116.14 - 144.06) | Sell |
ALXO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.29 | Buy |
| 20-day SMA: | 1.39 | Buy |
| 50-day SMA: | 1.62 | Sell |
| 200-day SMA: | 7.78 | Sell |
| 8-day EMA: | 1.32 | Buy |
| 20-day EMA: | 1.39 | Buy |
| 50-day EMA: | 1.84 | Sell |
| 200-day EMA: | 5.68 | Sell |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 122.06 | Buy |
| 20-day SMA: | 122.35 | Buy |
| 50-day SMA: | 118.69 | Buy |
| 200-day SMA: | 133.44 | Sell |
| 8-day EMA: | 123.06 | Buy |
| 20-day EMA: | 121.92 | Buy |
| 50-day EMA: | 122.46 | Buy |
| 200-day EMA: | 127.9 | Sell |
ALX Oncology Holdings Earnings Growth & ALXO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and a decrease next year of $0.58 per share.
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $1.13 per share.
ALX Oncology Holdings Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurocrine Biosciences Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||